Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - NUTRA PHARMA CORPFinancial_Report.xls
10-Q/A - AMENDMENT TO FORM 10-Q - NUTRA PHARMA CORPv329157_10qa.htm
EX-31.1 - EXHIBIT 31.1 - NUTRA PHARMA CORPv329157_ex31-1.htm

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Nutra Pharma Corp., (the "Company") on Form 10-Q for the quarterly period ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Rik Deitsch, the Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 28, 2012    
     
/s/ Rik J. Deitsch    
Rik J. Deitsch    
Chief Executive Officer and Chief Financial Officer